Skip to content

DR DE CEUNINCK

Active Private limited companyfounded 2016active for 10 yearsLange Leemstraat 332, 2018 AntwerpKBO/BCE: BE 0663.696.170

Lifetime

9 annual accounts with figures on one time axis
peak of €193,615 in 2017
€143,247▼ 6.8%
peak of €92,794 in 2024
€82,263▼ 11.3%
peak of €328,681 in 2024
€183,481▼ 44.2%
€171,348▼ 7.9%
peak of 0 FTE in 2018
-not published
Board1 name since 2016
1 director
Documentsfilings and deeds
03-07-202628 days before the deadline
2025micro format
Dividend €227,463Equity from €328,681 to €183,481

Key points

from the 2025 annual accounts

Equity

€183,481 ▼ 44.2%
328,6812024+82,263Profit-227,463Dividend183,4812025

DR DE CEUNINCK paid out €227,463 in dividends. That is 277% of the 2025 profit.

Turnover

≈ €260,000 estimated

The micro format states no turnover.

Filings

9 annual accounts since 2017
AprilJune31 JulyOctober20202025

The last five annual accounts were filed 28 to 75 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,733 companies had the same profile as DR DE CEUNINCK has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,733 companies, not a prediction for DR DE CEUNINCK. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • deed of 13-10-2016
  • 93 sharesdeed of 13-10-2016
  • 93 sharesdeed of 13-10-2016
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0663696170
appointed as director General meeting of 07-04-2022 · Gazette deed
First establishment Lange Leemstraat 332, Antwerp
Incorporation · Resignations & appointments · Restructuring Demerger: DR. KIEKENS (formerly DR. KIEKENS - DR. DE CEUNINCK) splits off to DR DE CEUNINCK · resigns as manager · appointed as manager · published on 13-10-2016 · Gazette deed
All 17 events

Comparable companies

same main activity, similar in size and age
Company
DR DE CEUNINCK Antwerp €354,829 €143,247 51.7% -
DE BRUG Brecht €305,894 €144,806 11.4% -
Huisartsenpraktijk Slagvelden Heist-op-den-Berg €313,749 €141,603 34.5% -
Vanderhoydonck Nicolaas Antwerp €402,533 €142,778 44.2% -
Dr. Edward Camerlynck, huisarts Merelbeke-Melle €328,883 €143,269 94.3% -
DR. MATHIAS VIAENE Waregem €322,943 €145,152 50.9% -
Huisarts Van Renterghem Kwinten Ghent €372,218 €154,496 78.2% -

These companies have the same main activity as DR DE CEUNINCK: general medical practice (NACE 86210). They are comparable in size and age: total assets between €306,000 and €403,000, founded between 2015 and 2018.

Official details

Source: KBO
Status
Active since 26-09-2016Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.257.661.6372018 Antwerp, since 01-10-2016
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

€354,829▼ 31.1%
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on DR DE CEUNINCK

DR DE CEUNINCK files the micro format. That format states no turnover. The gross margin fell from €193,615 in 2017 to €143,247 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR DE CEUNINCK

What is the company number of DR DE CEUNINCK?
The company number of DR DE CEUNINCK is 0663.696.170. The VAT number is the same number with BE in front: BE 0663.696.170.
Where is DR DE CEUNINCK based?
The registered office is at Lange Leemstraat 332, 2018 Antwerp.Company details
What does DR DE CEUNINCK do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR DE CEUNINCK?
DR DE CEUNINCK is a private limited company (BV).
When was DR DE CEUNINCK founded?
DR DE CEUNINCK was founded on 26-09-2016.
Is DR DE CEUNINCK still active?
Yes, DR DE CEUNINCK is an active enterprise in the KBO register.
What is the turnover of DR DE CEUNINCK?
The turnover in financial year 2025 is about €260,000. This figure is estimated from the gross margin of €143,247 and 30 comparable companies (NACE 86210). It probably lies between €210,000 and €320,000.Financials
Is DR DE CEUNINCK profitable?
In financial year 2025, DR DE CEUNINCK made a profit of €82,263.
Where can I find the annual accounts of DR DE CEUNINCK?
DR DE CEUNINCK filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR DE CEUNINCK due?
DR DE CEUNINCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.